Site of action of a serum inhibitor of erythropoiesis.
D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D001327:Autoimmune Diseases / Q000276:immunology*; D001665:Binding Sites; D001856:Bone Marrow Examination; D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006400:Hematocrit; D006418:Heme / Q000096:biosynthesis; D006452:Hemoglobinometry; D006801:Humans; D007106:Immune Sera; D007074:Immunoglobulin G; D066298:In Vitro Techniques; D007503:Iron Isotopes; D007958:Leukocyte Count; D051379:Mice; D009157:Myasthenia Gravis / Q000276:immunology*; D011696:Purpura, Thrombocytopenic / Q000276:immunology*; D051381:Rats; D012156:Reticulocytes / Q000187:drug effects; D012217:Rheumatoid Factor / Q000032:analysis
D000906:Antibodies; D000974:Antibodies, Antinuclear; D007106:Immune Sera; D007074:Immunoglobulin G; D007503:Iron Isotopes; D004921:Erythropoietin; D006418:Heme; D012217:Rheumatoid Factor